Accolade ACCD
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Accolade (ACCD)
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
Key Insights
Critical company metrics and information
Latest Closing Price
$6.97Market Cap
$569.30 MillionPrice-Earnings Ratio
-3.11Total Outstanding Shares
81.99 Million SharesTotal Employees
2,400Dividend
No dividendIPO Date
July 2, 2020SIC Description
Services-business Services, NecPrimary Exchange
NASDAQType
Common StockHeadquarters
660 w. germantown pike suite 500, Plymouth meeting, PA, 19462Homepage
https://www.accolade.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $-6.76 Million |
Net Cash Flow From Investing Activities | $-43.55 Million |
Net Cash Flow From Investing Activities, Continuing | $-43.55 Million |
Net Cash Flow, Continuing | $-44.09 Million |
Net Cash Flow | $-44.09 Million |
Net Cash Flow From Operating Activities | $-6.76 Million |
Income Statement
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Basic Average Shares | $239.17 Million |
Benefits Costs and Expenses | $625.25 Million |
Revenues | $446.72 Million |
Other Operating Expenses | $356.44 Million |
Net Income/Loss | $-180.30 Million |
Net Income/Loss Attributable To Parent | $-180.30 Million |
Comprehensive Income
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss | $-180.27 Million |
Other Comprehensive Income/Loss | $-180.27 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income/Loss Attributable To Parent | $-180.27 Million |
Balance Sheet
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Current Assets | $272.45 Million |
Noncurrent Liabilities | $230.87 Million |
Accounts Payable | $10.34 Million |
Wages | $33.45 Million |
Noncurrent Assets | $375.00 Million |
Equity | $313 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Recent Headlines From The Web
Latest news, press releases, and media coverage about ACCD from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.